The CBD industry would really, really, love to see the passage of U.S. House Bill 8179, which would make allow ingredients derived from hemp to become dietary supplements under the Federal Food, Drug, and Cosmetic Act. H.R. 2843, which would decriminalize marijuana, would be nice, too.
But in an election year, and with the necessary regulations still to be determined at the state or federal level, expectations for any immediate action on the dietary supplement issue remain low.
Still, that doesn’t mean that the many companies ramping up products infused with the cannabis plant compounds CBD (short for cannabidiol, one of 113 cannabinoids identified in the cannabis plant) or THC (psychoactive tetrahydrocannabinol) are lying low. They know their consumer audience is eager – and ready.
Read full article here: https://www.forbes.com/sites/joanoleck/2020/09/27/building-a-cannabis-infused-product-industry-has-challenges-but-also-rewards-like-an-215-billion-market-by-2025-new-report-says/?mc_cid=da20cc7d37&mc_eid=33e049eacb#683eac016538